10th April 2019
Cello Health plc (AIM: CLL), the healthcare-led advisory group, is this afternoon hosting a capital markets event in London for analysts and institutional investors. The event will focus on the Group's Cello Health division and its strategic growth opportunities in the pharmaceutical and biotechnology industries worldwide.
The event will begin at 2.30pm at the offices of Buchanan, 107 Cheapside, London EC2V 6DN. For further details please contact Buchanan on 020 7466 5000 or email cello@buchanan.uk.com.
A copy of the presentations accompanying the event will be made available later today at the Group's website: https://cellohealthplc.com.
No new material information will be disclosed during the event.
Enquiries:
Cello Healthplc | 020 7812 8460 |
Mark Scott, Chief Executive | |
Mark Bentley, Group Finance Director | |
Cenkos Securities (Nominated adviser and broker) | 020 7397 8900 |
Mark Connelly | |
Harry Hargreaves | |
Buchanan | 020 7466 5000 |
Mark Court | |
Jamie Hooper | |
Sophie Wills |
Attachments
- Original document
- Permalink
Disclaimer
Cello Group plc published this content on 10 April 2019 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 10 April 2019 07:57:01 UTC